More about
Nivolumab
News
September 24, 2021
2 min read
Save
Nivolumab plus rucaparib shows ‘noteworthy activity’ in subset of men with prostate cancer
News
September 20, 2021
1 min read
Save
FDA grants priority review to relatlimab-nivolumab regimen for advanced melanoma
News
September 17, 2021
3 min read
Save
Immunotherapy combination maintains OS advantage in malignant pleural mesothelioma
News
September 17, 2021
3 min read
Save
Nivolumab-ipilimumab combination confers durable benefit in advanced renal cell carcinoma
News
September 13, 2021
1 min read
Save
Nivolumab plus ipilimumab confers sustained OS benefit in malignant pleural mesothelioma
News
September 09, 2021
2 min read
Save
Addition of nivolumab, ipilimumab to chemotherapy extends OS in NSCLC with brain metastases
News
August 20, 2021
2 min read
Save
FDA approves Opdivo as adjuvant treatment of high-risk urothelial carcinoma
News
July 26, 2021
1 min read
Save
Bristol Myers Squibb withdraws liver cancer indication for nivolumab
News
July 16, 2021
1 min read
Save
Trial of nivolumab plus ipilimumab for first-line HNSCC misses primary endpoints
News
July 14, 2021
2 min watch
Save